Literature DB >> 15642798

Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle.

Richard R Almon1, Debra C Dubois, Jin Y Jin, William J Jusko.   

Abstract

Elevated systemic levels of glucocorticoids are causally related to peripheral insulin resistance. The pharmacological use of synthetic glucocorticoids (corticosteroids) often results in insulin resistance/type II diabetes. Skeletal muscle is responsible for close to 80% of the insulin-induced systemic disposal of glucose and is a major target for glucocorticoid-induced insulin resistance. We used Affymetrix gene chips to profile the dynamic changes in mRNA expression in rat skeletal muscle in response to a single bolus dose of the synthetic glucocorticoid methyl-prednisolone. Temporal expression profiles (analyzed on individual chips) were obtained from tissues of 48 drug-treated animals encompassing 16 time points over 72 h following drug administration along with four vehicle-treated controls. Data mining identified 653 regulated probe sets out of 8799 present on the chip. Of these 653 probe sets we identified 29, which represented 22 gene transcripts, that were associated with the development of insulin resistance. These 29 probe sets were regulated in three fundamental temporal patterns. 16 probe sets coding for 12 different genes had a profile of enhanced expression. 10 probe sets coding for eight different genes showed decreased expression and three probe sets coding for two genes showed biphasic temporal signatures. These transcripts were grouped into four general functional categories: signal transduction, transcription regulation, carbohydrate/fat metabolism, and regulation of blood flow to the muscle. The results demonstrate the polygenic nature of transcriptional changes associated with insulin resistance that can provide a temporal scaffolding for translational and post-translational data as they become available.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642798      PMCID: PMC2574435          DOI: 10.1677/joe.1.05953

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  81 in total

Review 1.  Antenatal corticosteroids: the good, the bad and the unknown.

Authors:  John P Newnham; Timothy J M Moss; Ilias Nitsos; Deborah M Sloboda
Journal:  Curr Opin Obstet Gynecol       Date:  2002-12       Impact factor: 1.927

Review 2.  Prenatal programming of postnatal endocrine responses by glucocorticoids.

Authors:  Caroline E Bertram; Mark A Hanson
Journal:  Reproduction       Date:  2002-10       Impact factor: 3.906

Review 3.  [Insulin resistance induced by drugs, inflammation and stress].

Authors:  Shoichi Tomono; Yoshio Ohyama; Tsuyoshi Uchiyama
Journal:  Nihon Rinsho       Date:  2002-07

4.  Interleukin-6 induces cellular insulin resistance in hepatocytes.

Authors:  Joseph J Senn; Peter J Klover; Irena A Nowak; Robert A Mooney
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

Review 5.  [Polymorphisms in insulin receptor substrate-1 (IRS-1) gene].

Authors:  Eiichi Araki; Kaku Tsuruzoe
Journal:  Nihon Rinsho       Date:  2002-07

6.  Up-regulation of SREBP-1c and lipogenic genes in skeletal muscles after exercise training.

Authors:  Shinobu Ikeda; Hiromi Miyazaki; Teruyo Nakatani; Yuko Kai; Yasutomi Kamei; Shinji Miura; Nobuyo Tsuboyama-Kasaoka; Osamu Ezaki
Journal:  Biochem Biophys Res Commun       Date:  2002-08-16       Impact factor: 3.575

7.  Heterozygous knockout of the IRS-1 gene in mice enhances obesity-linked insulin resistance: a possible model for the development of type 2 diabetes.

Authors:  A Shirakami; T Toyonaga; K Tsuruzoe; T Shirotani; K Matsumoto; K Yoshizato; J Kawashima; Y Hirashima; N Miyamura; C R Kahn; E Araki
Journal:  J Endocrinol       Date:  2002-08       Impact factor: 4.286

8.  Induction of insulin resistance by high-sucrose feeding does not raise mean arterial blood pressure but impairs haemodynamic responses to insulin in rats.

Authors:  Marta Santuré; Maryse Pitre; André Marette; Yves Deshaies; Christian Lemieux; Richard Larivière; André Nadeau; Hélène Bachelard
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

9.  Pharmacodynamics and pharmacogenomics of diverse receptor-mediated effects of methylprednisolone in rats using microarray analysis.

Authors:  Richard R Almon; Debra C DuBois; Emily H Brandenburg; Wei Shi; Shuzhong Zhang; Robert M Straubinger; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-04       Impact factor: 2.745

10.  Dietary cholesterol opposes PUFA-mediated repression of the stearoyl-CoA desaturase-1 gene by SREBP-1 independent mechanism.

Authors:  Hyoun-Ju Kim; Makoto Miyazaki; James M Ntambi
Journal:  J Lipid Res       Date:  2002-10       Impact factor: 5.922

View more
  20 in total

1.  Relationships between circadian rhythms and modulation of gene expression by glucocorticoids in skeletal muscle.

Authors:  Richard R Almon; Eric Yang; William Lai; Ioannis P Androulakis; Svetlana Ghimbovschi; Eric P Hoffman; William J Jusko; Debra C Dubois
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-30       Impact factor: 3.619

Review 2.  Corticosteroid-induced adverse events in adults: frequency, screening and prevention.

Authors:  Laurence Fardet; Abdulrhaman Kassar; Jean Cabane; Antoine Flahault
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it.

Authors:  Heather A Ferris; C Ronald Kahn
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

Review 4.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

5.  Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens.

Authors:  Richard R Almon; Debra C DuBois; Zhenling Yao; Eric P Hoffman; Svetlana Ghimbovschi; William J Jusko
Journal:  Physiol Genomics       Date:  2007-05-01       Impact factor: 3.107

Review 6.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

7.  Mathematical modeling of corticosteroid pharmacogenomics in rat muscle following acute and chronic methylprednisolone dosing.

Authors:  Zhenling Yao; Eric P Hoffman; Svetlana Ghimbovschi; Debra C Dubois; Richard R Almon; William J Jusko
Journal:  Mol Pharm       Date:  2008-02-14       Impact factor: 4.939

8.  Pharmacodynamic/pharmacogenomic modeling of insulin resistance genes in rat muscle after methylprednisolone treatment: exploring regulatory signaling cascades.

Authors:  Zhenling Yao; Eric P Hoffman; Svetlana Ghimbovschi; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Gene Regul Syst Bio       Date:  2008-04-23

9.  Pharmacodynamic modeling of acute and chronic effects of methylprednisolone on hepatic urea cycle genes in rats.

Authors:  Anasuya Hazra; Debra C DuBois; Richard R Almon; Grayson H Snyder; William J Jusko
Journal:  Gene Regul Syst Bio       Date:  2008-02-14

10.  Assessing the dynamics of nuclear glucocorticoid-receptor complex: adding flexibility to gene expression modeling.

Authors:  Anasuya Hazra; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-02-07       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.